Clinical Trials
37
Active:0
Completed:37
Trial Phases
3 Phases
Phase 1:3
Phase 3:22
Not Applicable:5
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (30 trials with phase data)• Click on a phase to view related trials
Phase 3
22 (73.3%)Not Applicable
5 (16.7%)Phase 1
3 (10.0%)Bioequivalence Study of Two Treatments for the Treatment of Plaque Psoriasis
Phase 3
Completed
- Conditions
- Plaque Psoriasis
- Interventions
- First Posted Date
- 2023-03-10
- Last Posted Date
- 2024-08-12
- Lead Sponsor
- Padagis LLC
- Target Recruit Count
- 414
- Registration Number
- NCT05763082
- Locations
- 🇺🇸
DS Research, Louisville, Kentucky, United States
To Compare the Efficacy and Safety of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes
Phase 3
Completed
- Conditions
- Ocular HypertensionGlaucoma, Open-Angle
- Interventions
- Drug: Brinzolamide/brimonidine ophthalmic suspension
- First Posted Date
- 2021-06-29
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- Padagis LLC
- Target Recruit Count
- 447
- Registration Number
- NCT04944290
- Locations
- 🇺🇸
James D. Branch Ophthalmology, Winston-Salem, North Carolina, United States
To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Secondarily Infected Traumatic Skin Lesions
Phase 3
Completed
- Conditions
- Secondarily Infected Traumatic Skin Lesions
- Interventions
- Drug: Vehicle
- First Posted Date
- 2019-11-07
- Last Posted Date
- 2022-11-03
- Lead Sponsor
- Padagis LLC
- Target Recruit Count
- 657
- Registration Number
- NCT04155203
- Locations
- 🇺🇸
Palm Beach Research Center, West Palm Beach, Florida, United States
To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes
Phase 3
Completed
- Conditions
- Glaucoma, Open-AngleOcular Hypertension
- Interventions
- First Posted Date
- 2019-07-18
- Last Posted Date
- 2023-03-06
- Lead Sponsor
- Padagis LLC
- Target Recruit Count
- 495
- Registration Number
- NCT04024072
- Locations
- 🇺🇸
James D. Branch Ophthalmology, Winston-Salem, North Carolina, United States
Bioequivalence Study of Two Treatments in the Treatment of Acne Vulgaris on the Face
Phase 3
Completed
- Conditions
- Acne Vulgaris
- Interventions
- First Posted Date
- 2018-01-08
- Last Posted Date
- 2021-11-08
- Lead Sponsor
- Padagis LLC
- Target Recruit Count
- 825
- Registration Number
- NCT03393494
- Locations
- 🇺🇸
Dermatology Consultants, High Point, North Carolina, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 8
- Next
News
No news found